NEWS
- FGF21 agonist for MASH: Current Status
- In Vivo CAR-T Delivery: mRNA-LNP System
- Next-Generation mRNA-LNPs: Strategies to Reduce Anti-PEG Antibody Responses
- CD388, a Novel Drug Fc-Conjugate (DFC) to Prevent Influenza Infection
- 21 Antibody-drug Conjugates (ADCs) Approved by FDA/EMA/NMPA/PMDA
- PEGylated Liposomes in the Clinic and Clinical Trials
- PEG Lipids: Definition, Structure & Key Applications
- The Applications and Challenges of Lipid Nanoparticles
- Liposomes vs. Lipid Nanoparticles: Which Is Best for Drug Delivery?
- The Role of Four Lipid Components Of LNPs